Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020165

Expand all

NICODERM CQ (NICOTINE)
7MG/24HR
Marketing Status: Over-the-counter
Active Ingredient: NICOTINE
Proprietary Name: NICODERM CQ
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 7MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020165
Product Number: 006
Approval Date: Aug 2, 1996
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Over-the-counter
Patent and Exclusivity Information
NICODERM CQ (NICOTINE)
14MG/24HR
Marketing Status: Over-the-counter
Active Ingredient: NICOTINE
Proprietary Name: NICODERM CQ
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 14MG/24HR
Reference Listed Drug: Yes
Reference Standard: No
TE Code: 
Application Number: N020165
Product Number: 005
Approval Date: Aug 2, 1996
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Over-the-counter
Patent and Exclusivity Information
NICODERM CQ (NICOTINE)
21MG/24HR
Marketing Status: Over-the-counter
Active Ingredient: NICOTINE
Proprietary Name: NICODERM CQ
Dosage Form; Route of Administration: FILM, EXTENDED RELEASE; TRANSDERMAL
Strength: 21MG/24HR
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N020165
Product Number: 004
Approval Date: Aug 2, 1996
Applicant Holder Full Name: SANOFI AVENTIS US LLC
Marketing Status:  Over-the-counter
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English